Abstract
Supplementary Data from Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1158/1078-0432.22487466.v1
Copy DOIPublication Date: Mar 31, 2023 |
License type: CC BY 4.0 |
Supplementary Data from Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Join us for a 30 min session where you can share your feedback and ask us any queries you have